Ignite Creation Date:
2025-12-24 @ 11:42 PM
Ignite Modification Date:
2026-01-03 @ 5:11 AM
Study NCT ID:
NCT05157451
Status:
WITHDRAWN
Last Update Posted:
2023-03-23
First Post:
2021-12-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Y-90 Versus SBRT for Inoperable HCC
Sponsor:
OHSU Knight Cancer Institute
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Hepatocellular Carcinoma | View |
| None | Stage I Hepatocellular Carcinoma AJCC v8 | View |
| None | Stage IA Hepatocellular Carcinoma AJCC v8 | View |
| None | Stage IB Hepatocellular Carcinoma AJCC v8 | View |
| None | Stage II Hepatocellular Carcinoma AJCC v8 | View |
| None | Stage III Hepatocellular Carcinoma AJCC v8 | View |
| None | Stage IIIA Hepatocellular Carcinoma AJCC v8 | View |
| None | Stage IIIB Hepatocellular Carcinoma AJCC v8 | View |
| None | Stage IVA Hepatocellular Carcinoma AJCC v8 | View |
Keywords: